Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,281
Closed -$223K 248
2023
Q3
$223K Buy
20,281
+8,852
+77% +$127K 0.05% 172
2023
Q2
$180K Sell
11,429
-1,092,424
-99% -$12.7M 0.04% 185
2023
Q1
$14.4M Buy
1,103,853
+1,068,539
+3,026% +$8.77M 2.98% 3
2022
Q4
$384K Sell
35,314
-304,221
-90% -$3.74M 0.08% 84
2022
Q3
$5.45M Sell
339,535
-111,238
-25% -$1.64M 1.72% 11
2022
Q2
$3.51K Hold
450,773
0.2% 43
2022
Q1
$5.63K Buy
450,773
+6,920
+2% +$97.1K 0.28% 30
2021
Q4
$10.6K Buy
+443,853
New +$10.7M 0.44% 23
2021
Q2
Sell
-27,086
Closed -$315K 179
2021
Q1
$315K Buy
+27,086
New +$356K 0.05% 159

Other funds holding ENVX

Wexford Capital's ENVX Position: Q4 2023 in Review

Wexford Capital sold out of Enovix (ENVX) in Q4 2023, closing a stake of 20,281 shares — an estimated $223K sold.

Wexford Capital first reported a position in ENVX in Q1 2021 and held it in 9 quarters. The position peaked at $14.4M in Q1 2023. 286 funds tracked by Wall St. Rank hold ENVX as of Q4 2023.

  • Wexford Capital reported no remaining Enovix position as of Q4 2023 after selling out during the quarter.
  • Wexford Capital sold 20,281 Enovix shares in Q4 2023, an estimated $223K.
  • Wexford Capital first reported a position in Enovix in Q1 2021 and held it in 9 quarters.
  • Wexford Capital's Enovix position peaked at $14.4M in Q1 2023.
  • 286 funds tracked by Wall St. Rank held Enovix as of Q4 2023.

Based on Wexford Capital's 13F filing for Q4 2023, filed 15 Feb 2024.